Cite
MLA Citation
B Bressler et al.. “P546 Vedolizumab outcomes in real-world bio-naive ulcerative colitis and Crohn's disease patients (EVOLVE) in Canada: Interim results.” Journal of Crohn's and colitis, vol. 12, n.d., p. S382. http://access.bl.uk/ark:/81055/vdc_100095502796.0x000019